Active kinase proteome screening reveals novel signal complexity in cardiomyopathy

被引:9
作者
Fernando, P
Deng, W
Pekalska, B
DeRepentigny, Y
Kothary, R
Kelly, JF
Megeney, LA
机构
[1] Ottawa Gen Hosp, Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada
[2] CNR, Inst Biol Sci, Ottawa, ON K1A 0R63, Canada
[3] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada
关键词
D O I
10.1074/mcp.M400200-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Recent advances in the characterization of the phosphoproteome have been limited to measuring phosphorylation statuses, which imply but do not measure protein kinase activity directly. As such, the ability to screen, compare, and define multiple protein enzymatic activities across divergent samples remains a daunting challenge in proteomics. Here, we describe a gel-based kinase assay coupled to MS identification as an approach to map global kinase activity and assign pathway architecture to specified biologic contexts. We demonstrate the utility of this method as a platform for the comparison of proteomes based on differences in both kinase activities and for use in the de novo substrate identification for individual kinases. This approach allowed us to map the signal perturbations in the post-natal heart that were associated with activation of a myopathic cascade as mediated by the mitogen-activated protein kinase MKK6 and established the novel observation that MKK6 promotes the development of cardiomyopathy through multiple substrate interactions.
引用
收藏
页码:673 / 682
页数:10
相关论文
共 38 条
[1]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[2]   EVALUATION OF 2-DIMENSIONAL PHOSPHOPEPTIDE MAPS BY ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY OF RECOVERED PEPTIDES [J].
AFFOLTER, M ;
WATTS, JD ;
KREBS, DL ;
AEBERSOLD, R .
ANALYTICAL BIOCHEMISTRY, 1994, 223 (01) :74-81
[3]   Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength [J].
Alonso, G ;
Ambrosino, C ;
Jones, M ;
Nebreda, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40641-40648
[4]   Specificity determinants in MAPK signaling to transcription factors [J].
Barsyte-Lovejoy, D ;
Galanis, A ;
Sharrocks, AD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) :9896-9903
[5]   Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NEAT signaling [J].
Braz, JC ;
Bueno, OF ;
Liang, QR ;
Wilkins, BJ ;
Dai, YS ;
Parsons, S ;
Braunwart, J ;
Glascock, BJ ;
Klevitsky, R ;
Kimball, TF ;
Hewett, TE ;
Molkentin, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1475-1486
[6]   Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death [J].
Bueno, OF ;
Molkentin, JD .
CIRCULATION RESEARCH, 2002, 91 (09) :776-781
[7]  
CICIRELLI MF, 1988, J BIOL CHEM, V263, P2009
[8]   Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure [J].
de Tombe, PP ;
Solaro, RJ .
ANNALS OF BIOMEDICAL ENGINEERING, 2000, 28 (08) :991-1001
[9]   Structural bases for CRMP function in plexin-dependent semaphorin3A signaling [J].
Deo, RC ;
Schmidt, EF ;
Elhabazi, A ;
Togashi, H ;
Burley, SK ;
Strittmatter, SM .
EMBO JOURNAL, 2004, 23 (01) :9-22
[10]   Caspase 3 activity is required for skeletal muscle differentiation [J].
Fernando, P ;
Kelly, JF ;
Balazsi, K ;
Slack, RS ;
Megeney, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11025-11030